These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 7533609)

  • 41. Restoration of cyclic adenosine monophosphate-stimulated chloride channel activity in human cystic fibrosis tracheobronchial submucosal gland cells by adenovirus-mediated and cationic lipid-mediated gene transfer.
    Jiang C; Finkbeiner WE; Widdicombe JH; Fang SL; Wang KX; Nietupski JB; Hehir KM; Cheng SH
    Am J Respir Cell Mol Biol; 1999 Jun; 20(6):1107-15. PubMed ID: 10340929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.
    Flotte TR; Afione SA; Conrad C; McGrath SA; Solow R; Oka H; Zeitlin PL; Guggino WB; Carter BJ
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10613-7. PubMed ID: 7504271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.
    Kwilas AR; Yednak MA; Zhang L; Liesman R; Collins PL; Pickles RJ; Peeples ME
    J Virol; 2010 Aug; 84(15):7770-81. PubMed ID: 20504917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice.
    Vidović D; Carlon MS; da Cunha MF; Dekkers JF; Hollenhorst MI; Bijvelds MJ; Ramalho AS; Van den Haute C; Ferrante M; Baekelandt V; Janssens HM; De Boeck K; Sermet-Gaudelus I; de Jonge HR; Gijsbers R; Beekman JM; Edelman A; Debyser Z
    Am J Respir Crit Care Med; 2016 Feb; 193(3):288-98. PubMed ID: 26509335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cationic lipids for reporter gene and CFTR transfer to rat pulmonary epithelium.
    Logan JJ; Bebok Z; Walker LC; Peng S; Felgner PL; Siegal GP; Frizzell RA; Dong J; Howard M; Matalon
    Gene Ther; 1995 Jan; 2(1):38-49. PubMed ID: 7536114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cationic lipid:pDNA complexes for the treatment of cystic fibrosis.
    Eastman SJ; Scheule RK
    Curr Opin Mol Ther; 1999 Apr; 1(2):186-96. PubMed ID: 11715942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis.
    Jiang Q; Engelhardt JF
    Eur J Hum Genet; 1998 Jan; 6(1):12-31. PubMed ID: 9781011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radioisotopic imaging allows optimization of adenovirus lung deposition for cystic fibrosis gene therapy.
    Lerondel S; Le Pape A; Sené C; Faure L; Bernard S; Diot P; Nicolis E; Mehtali M; Lusky M; Cabrini G; Pavirani A
    Hum Gene Ther; 2001 Jan; 12(1):1-11. PubMed ID: 11177537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses.
    Imler JL; Bout A; Dreyer D; Dieterlé A; Schultz H; Valerio D; Mehtali M; Pavirani A
    Hum Gene Ther; 1995 Jun; 6(6):711-21. PubMed ID: 7548271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Episomal expression of wild-type CFTR corrects cAMP-dependent chloride transport in respiratory epithelial cells.
    Lei DC; Kunzelmann K; Koslowsky T; Yezzi MJ; Escobar LC; Xu Z; Ellison AR; Rommens JM; Tsui L-C ; Tykocinski M; Gruenert DC
    Gene Ther; 1996 May; 3(5):427-36. PubMed ID: 9156804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
    Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
    J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytokine pattern in cystic fibrosis patients during antibiotic therapy and gene therapy using adenoviral vector.
    Reix P; Bellon G; Bienvenu J; Pavirani A; Levrey-Hadden H
    Eur Cytokine Netw; 2002; 13(3):324-30. PubMed ID: 12231476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ability of a chimeric cAMP-responsive promoter to confer pharmacologic control of CFTR cDNA expression and cAMP-mediated Cl- secretion.
    Suzuki M; Singh RN; Crystal RG
    Gene Ther; 1997 Nov; 4(11):1195-201. PubMed ID: 9425443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transfer of a constitutive viral promoter-cystic fibrosis transmembrane conductance regulator cDNA to human epithelial cells conveys resistance to down-regulation of cAMP-regulated Cl- secretion in the presence of inflammatory stimuli.
    Kobayashi N; Rosenthal ER; Yoshimura K; Crystal RG
    Nucleic Acids Res; 1994 Oct; 22(21):4470-6. PubMed ID: 7526342
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased contact time improves adenovirus-mediated CFTR gene transfer to nasal epithelium of CF mice.
    Jiang C; Akita GY; Colledge WH; Ratcliff RA; Evans MJ; Hehir KM; St George JA; Wadsworth SC; Cheng SH
    Hum Gene Ther; 1997 Apr; 8(6):671-80. PubMed ID: 9113507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis.
    Zabner J; Couture LA; Gregory RJ; Graham SM; Smith AE; Welsh MJ
    Cell; 1993 Oct; 75(2):207-16. PubMed ID: 7691415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates.
    Wilmott RW; Amin RS; Perez CR; Wert SE; Keller G; Boivin GP; Hirsch R; De Inocencio J; Lu P; Reising SF; Yei S; Whitsett JA; Trapnell BC
    Hum Gene Ther; 1996 Feb; 7(3):301-18. PubMed ID: 8835218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.
    Crystal RG; Mastrangeli A; Sanders A; Cooke J; King T; Gilbert F; Henschke C; Pascal W; Herena J; Harvey BG
    Hum Gene Ther; 1995 May; 6(5):667-703. PubMed ID: 7578402
    [No Abstract]   [Full Text] [Related]  

  • 60. ICAM-1 induction in respiratory cells exposed to a replication-deficient recombinant adenovirus in vitro and in vivo.
    Nicolis E; Tamanini A; Melotti P; Rolfini R; Berton G; Cassatella MA; Bout A; Pavirani A; Cabrini G
    Gene Ther; 1998 Jan; 5(1):131-6. PubMed ID: 9536274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.